Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality

Studies assessing patient-centred outcomes of novel rifampicin resistant tuberculosis (RR-TB) diagnostics are rare and mostly apply conventional methods which may not adequately address biases. Even though the Xpert MTB/RIF molecular assay was endorsed a decade ago for simultaneous diagnosis of tube...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vos, Elise, Westreich, Daniel, Scott, Lesley, Voss de Lima, Yara, Stevens, Wendy, Hayes, Cindy, da Silva, Pedro, Van Rie, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473529/
https://www.ncbi.nlm.nih.gov/pubmed/37656670
http://dx.doi.org/10.1371/journal.pgph.0001989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473529/
https://www.ncbi.nlm.nih.gov/pubmed/37656670
http://dx.doi.org/10.1371/journal.pgph.0001989

Ejemplares similares